ESENTRA 120 mg injection is a prescription medication containing the active ingredient Denosumab, which is a monoclonal antibody that treats bone loss and strengthen bones by blocking a specific protein that causes bone breakdown . manufactured by intas pharmaceutical , is a prescription Denosumab injection used to strengthen bones, increase bone density and reduce the risk of fractures . it works as a monoclonal antibody that inhibits the RANK ligand protein ,which is responsible for bone breakdown.

WHAT IS ESENTRA 120 MG INJECTION PFS?

ESENTRA 120 mg is a prescription biological medication and monoclonal antibody . it is classified as Rank ligand (RANKL) inhibitor and functions as a bone resorption inhibitor . BY binding to RANKAL proteins, it prevents cells called osteoclasts from breaking down bone, thereby increasing bone density and decreasing the risk of fractures .

Key classification:

• Drug class: RANK ligand (RANKL) inhibitor ,monoclonal antibody

• Therapeutic use: bone resorption inhibitor ,Bone-targeting Agent

• Active ingredient: Denosumab 120 mg

• Medical application: used to strengthen bones , treat osteoporosis and prevent skeletal complications /fractures in patients with cancer or bone metastases .

WHAT ARE THE MEDICAL USES OF ESENTRA 120 MG INJECTION PFS?

Medical uses of ESENTRA 120 MG Injection PFS are:

A) Prevention of skeletal –Related Events (SREs)

ESENTRA 120 MG is a targeted biological therapy used in oncology to prevent skeletal-related events (SREs) –such as pathological fracture , spinal cord compression ,or the need for bone radiation and surgery .

ESENTRA 120 MG Injection is used in:

• In patients with bone metastases from solid tumors

ESENTRA 120mg is a targeted biological therapy used to prevent skeletal-related events in patients with bone metastases from solid tumor. It is a monoclonal antibody that inhibits RANKL protein to reduce bone breakdown.

• Reduction of Fracture risk and bone complications

ESENTRA 120mg is a targeted monoclonal antibody used to strengthen bones, slow bone breakdown and significantly reduce the risk of fractures and skeletal complications in cancer and osteoporosis patients .

How it works

• RANK ligand Inhibition: ESENTRA binds to and inhibits a protein called RANK ligand , stopping cells from breaking down bone tissues while allowing bone –building cells to thrive.

• Increased Density: it builds bone mass and strengthens the skeleton, effectively preventing fractures in the spine, hip and other vulnerable bones.

B) Giant cell tumor of Bone

ESENTRA 120 mg is a targeted monoclonal antibody prescribed for adults and mature adolescents with Giant cell tumor of bone (GCTB) that is surgically unresectable or when surgery would cause severe morbidity . it works by inhibiting the RANKAL protein ,slowing tumor growth and shrinking the mass.

ESENTRA 120 mg used in

• Management of unresectable tumors

ESENTRA 120 mg is utilized to prevent skeletal complications from bone metastases and is specifically indicated for treating giant cell tumors of the bone (GCTB) that cannot be managed by surgery .

How it works?

• Tumor Control : for GCTB, denosumab slows tumor growth and reduces the size of the mass by directly targeting and blocking receptors in the tumor cells.

• Bone Repair: it decreases bone resorption , encourages ossification (hardening ) of the tumor area, and strengthen the bone.

• Dosing Schedule : for oncology indications, it is typically administered as a subcutaneous injection once every 4 weeks by a healthcare professional.

• Treatment when surgery is not appropriate

ESSENTRA 120mg is a targeted monoclonal antibody indicated for adults with inoperable or advanced Giant cell Tumor of Bone (GCTB) where surgery is unsuitable . it works by binding to and inhibiting RANKL, halting tumor progression and increasing bone strength .

• Dosing schedule : 120mg given every 4 weeks.

C) Hypercalcemia of malignancy

ESENTRA 120 mg is a targeted monoclonal antibody indicated to treat hyperglycemia of malignancy (HCM) that is refactory to standard intravenous bisphosphonate therapy.

• Management of elevated calcium level associated with cancer

ESENTRA 120 mg injection contains denosumab , a targeted monoclonal antibody used to treat Hypercalcemia of malignancy (HCM). It is typically reserved for patients whose elevated calcium level do not respond to intravenous bisphosphonate therapy.

How it works?

Elevated calcium in cancer (HCM) is often caused by tumors breaking down the bone. ESENTRA is administered according to specific schedule ,which may include initial doses on specific days of the first month, followed by regular intervals, to manage serum calcium levels.

• Used when other treatments are ineffective

ESENTRA 120 mg is a targeted monoclonal antibody injection used when standard treatments are ineffective or cannot be tolerated. It inhibits RANKL, a protein that causes bone breakdown , helping to prevent fractures and slow tumor growth.

HOW ESENTRA 120MG INJECTION WORK?

ESENTRA 120mg is a targeted monoclonal antibody used to strengthen bones and treat bone-related cancers. It works by blocking a specific protein (RANKL) that triggers bone breakdown, thereby slowing bone loss and increasing bone density.

• Mechanism of action :

Our bones are continuously broken down and rebuilt by cells called osteoclasts and osteoblasts. A protein in the body known as RANKL activates osteoclast, leading to the rapid erosion of bone tissue. ESENTRA acts like a shield ,binding directly to RANKL so it cannot attach to the osteoclast. By blocking this signal, osteoclast are rendered inactive or die off, significantly slowing down bone resorption . this allows the bone-building cells to outpace the breakdown ,increasing bone mass and preventing fractures.

• Reduction of bone resorption

ESENTRA 120 mg works exactly by reducing bone resorption. Normally, the bones are constantly broken down by cells called osteoclast and rebuild by cells called osteoblasts. this breakdown process is triggered by the protein in the body .BY blocking this protein, it stops osteoclast from forming, functioning or surviving . because the cells breaking down the bone are deactivated ,bone reabsorption is significantly reduced . this decrease bone destruction ,increases bone mass and lower the risk of fracture.

CONCLUSION

ESENTRA 120 is a targeted monoclonal antibody that effectively manages bone-related conditions by inhibiting RANKL , a protein responsible for bone breakdown. It strengthen bones ,increases bone mineral density and lowers fracture risk. It is also used to manage tumor growth and lower high calcium levels caused by malignancies.

FREQUENTLY ASKED QUESTIONS (FAQs):

QUESTION: WHAT IS ESENTRA 120 MG INJECTION USED FOR?

ESENTRA 120mg injection is a targeted medication that prevents bone breakdown. It is primarily used to strengthen bones in osteoporosis and manage cancer –related bone complications ,including preventing bone fractures, treating high calcium levels ,and slowing the growth of specific bone tumors.

QUESTION: HOW DOES DENOSUMAB WORK?

Denosumab is a monoclonal antibody that treat bone loss by inhibiting specialized cells called osteoclast , which naturally breakdown bone tissue . By neutralizing the protein called RANKL, it stops osteoclast from forming and functioning ,effectively preventing bone reabsorption and increasing bone mass.

QUESTION: WHY IS CALCIUM SUPPLEMENTATION IMPORTANT DURING TREATMENT ?

Calcium supplements are strictly required during ESENTRA treatment to prevent severe symptoms hypocalcemia . ESENTRA works by blocking a protein called RANK ligand , which stops the body from breaking down bone tissue .

REFERENCES:

1)https://www.1mg.com/drugs/esentra-120-injection-730533?srsltid=AfmBOooHZKKS7nTGdaRaKhH83363GYT2mvXV0g94vF9aYDODrJX1zwwz&wpsrc=Google+Organic+Search

2)https://m.indiamart.com/proddetail/120mg-esentra-denosumab-solution-injection-26429353055.html